Role of health insurance on the survival of infants with congenital heart defects

American Journal of Public Health

Volumn 104, Issue 9, 2014, Pages

  Kucik, James E ^a   Cassell, Cynthia H ^a   Alverson, Clinton J ^a   Donohue, Pamela ^b   Tanner, Jean Paul ^c   Minkovitz, Cynthia S ^d   Correia, Jane ^e   Burke, Thomas ^d   Kirby, Russell S ^c  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANCESTRY GROUP; ARTICLE; BIRTH WEIGHT; CONGENITAL HEART MALFORMATION; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH INSURANCE; HUMAN; KAPLAN MEIER METHOD; MALE; MEDICALLY UNINSURED; MORTALITY; NEWBORN; NEWBORN INTENSIVE CARE; PRENATAL CARE; REGISTER; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICS; UNITED STATES;

BIRTH WEIGHT; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; FLORIDA; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; INSURANCE, HEALTH; INTENSIVE CARE UNITS, NEONATAL; KAPLAN-MEIER ESTIMATE; MALE; MEDICALLY UNINSURED; PRENATAL CARE; REGISTRIES; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 84906088013     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.301969     Document Type: Article

References (58)

1. US Patient Protection and Affordable Care Act, Pub L No. 111-148, §2702, 124 Stat. 119, 318-319 (2010).
2. US Balanced Budget Act of 1997, Pub L No. 105-33, 111 Stat. 251, enacted August 5, 1997.
3. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol. 1985;121(1): 31-36.
4. Jenkins KJ, Newburger JW, Lock JE, Davis RB, Coffman GA, Iezzoni LI. In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload. Pediatrics. 1995;95(3):323-330.
5. Yang Q, Chen H, Correa A, Devine O, Mathews TJ, Honein MA. Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol. 2006;76(10):706-713.
6. Benavidez OJ, Gauvreau K, Jenkins KJ. Racial and ethnic disparities in mortality following congenital heart surgery. Pediatr Cardiol. 2006;27(3):321-328.
7. Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010;122(22): 2254-2263.
8. Gonzalez PC, Gauvreau K, Demone JA, Piercey GE, Jenkins KJ. Regional racial and ethnic differences in mortality for congenital heart surgery in children may reflect unequal access to care. Pediatr Cardiol. 2003; 24(2):103-108.
9. Nembhard WN, Salemi JL, Ethen MK, Fixler DE, Dimaggio A, Canfield MA. Racial/ethnic disparities in risk of early childhood mortality among children with congenital heart defects. Pediatrics. 2011;127(5):e1128-e1138.
10. U.S. Department of Health and Human Services. Healthy People 2020. Available at: http://www. healthypeople.gov/2020/topicsobjectives2020/ objectiveslist.aspx?topicId=26. Accessed October 12, 2012.
11. DeMone JA, Gonzalez PC, Gauvreau K, Piercey GE, Jenkins KJ. Risk of death for Medicaid recipients undergoing congenital heart surgery. Pediatr Cardiol. 2003; 24(2):97-102.
12. Jenkins PC, Flanagan MF, Jenkins KJ, et al. Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome. J Am Coll Cardiol. 2000;36(4):1178-1185.
13. Aly H, Bianco-Batlles D, Mohamed MA, Hammad TA. Mortality in infants with congenital diaphragmatic hernia: a study of the United States National Database. J Perinatol. 2010;30(8):553-557.
14. Jenkins KJ, Gauvreau K. Center-specific differences in mortality: preliminary analyses using the Risk Adjustment in Congenital Heart Surgery (RACHS-1) method. J Thorac Cardiovasc Surg. 2002;124(1):97-104.
15. Bol KA, Collins JS, Kirby RS, National Birth Defects Prevention Network. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics. 2006;117(3):803-813.
16. Kucik JE, Shin M, Siffel C, Marengo L, Correa A, Congenital Anomaly Multistate Prevalence and Survival Collaborative. Trends in survival among children with Down syndrome in 10 regions of the United States. Pediatrics. 2013;131(1):e27-e36.
17. Rasmussen SA, Wong LY, Correa A, Gambrell D, Friedman JM. Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J Pediatr. 2006; 148(6):806-812.
18. Shin M, Kucik JE, Correa A. Causes of death and case fatality rates among infants with Down syndrome in metropolitan Atlanta. Birth Defects Res A Clin Mol Teratol. 2007;79(11):775-780.
19. Shin M, Kucik JE, Siffel C, et al. Improved survival among children with spina bifida in the United States. J Pediatr. 2012;161(6):1132-1137.
20. Hirsch JC, Copeland G, Donohue JE, Kirby RS, Grigorescu V, Gurney JG. Population-based analysis of survival for hypoplastic left heart syndrome. J Pediatr. 2011;159(1):57-63.
21. Wang Y, Hu J, Druschel CM, Kirby RS. Twenty-fiveyear survival of children with birth defects in New York State: a population-based study. Birth Defects Res A Clin Mol Teratol. 2011;91(12):995-1003.
22. Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 2013;131(5):e1502-e1508.
23. Honein MA, Paulozzi LJ. Birth defects surveillance: assessing the "gold standard." Am J Public Health. 1999; 89(8):1238-1240.
24. International Classification of Diseases, Ninth Revision, Clinical Modification. Hyattsville, Md: National Center for Health Statistics; 1980. DHHS publication PHS 80-1260.
25. Florida Agency for Health Care Administration. Available at: http://ahca.myflorida.com. Accessed September 7, 2012.
26. Salemi JL, Tanner JP, Block S, et al. The relative contribution of data sources to a birth defects registry utilizing passive multisource ascertainment methods: does a smaller birth defects case ascertainment net lead to overall or disproportionate loss? J Registry Manag. 2011;38(1):30-38.
27. Salemi JL, Tanner JP, Kennedy S, et al. A comparison of two surveillance strategies for selected birth defects in Florida. Public Health Rep. 2012;127(4):391-400.
28. Miller A, Siffel C, Lu C, Riehle-Colarusso T, Frias JL, Correa A. Long-term survival of infants with atrioventricular septal defects. J Pediatr. 2010;156(6):994-1000.
29. Committee on Fetus and Newborn. Levels of neonatal care. Pediatrics. 2004;114(5):1341-1347.
30. Kotelchuck M. The Adequacy of Prenatal Care Utilization Index: its US distribution and association with low birthweight. Am J Public Health. 1994;84(9):1486-1489.
31. Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation. 2009;120(5):447-458.
32. Kaplan ELMP. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282): 457-481.
33. Greenwood M. The Natural Duration of Cancer. Reports on Public Health and Medical Subjects. London, UK: His Majesty's Stationery Office; 1926;1-26.
34. Cox DROD. Analysis of Survival Data. London, UK: Chapman &Hall; 1984.
35. Skinner AC, Mayer ML. Effects of insurance status on children's access to specialty care: a systematic review of the literature. BMC Health Serv Res. 2007;7:194.
36. Nell S, Wijngaarde CA, Pistorius LR, et al. Fetal heart disease: severity, associated anomalies and parental decision. Fetal Diagn Ther. 2013;33(4):235-240.
37. Perlstein MA, Goldberg SJ, Meaney FJ, Davis MF, Zwerdling Kluger C. Factors influencing age at referral of children with congenital heart disease. Arch Pediatr Adolesc Med. 1997;151(9):892-897.
38. Chang RK, Chen AY, Klitzner TS. Factors associated with age at operation for children with congenital heart disease. Pediatrics. 2000;105(5):1073-1081.
39. Howell EA, Hebert P, Chatterjee S, Kleinman LC, Chassin MR. Black/white differences in very low birth weight neonatal mortality rates among New York City hospitals. Pediatrics. 2008;121(3):e407-e415.
40. Nembhard WN, Pathak EB, Schocken DD. Racial/ ethnic disparities in mortality related to congenital heart defects among children and adults in the United States. Ethn Dis. 2008;18(4):442-449.
41. Oster ME, Strickland MJ, Mahle WT. Racial and ethnic disparities in post-operative mortality following congenital heart surgery. J Pediatr. 2011;159(2):222-226.
42. Fixler DE, Nembhard WN, Xu P, Ethen MK, Canfield MA. Effect of acculturation and distance from cardiac center on congenital heart disease mortality. Pediatrics. 2012;129(6):1118-1124.
43. Andersen RM, McCutcheon A, Aday LA, Chiu GY, Bell R. Exploring dimensions of access to medical care. Health Serv Res. 1983;18(1):49-74.
44. Barnato AE, Lucas FL, Staiger D, Wennberg DE, Chandra A. Hospital-level racial disparities in acute myocardial infarction treatment and outcomes. Med Care. 2005;43(4):308-319.
45. Howell EA. Racial disparities in infant mortality: a quality of care perspective. Mt Sinai J Med. 2008;75 (1):31-35.
46. Correa A, Cragan JD, Kucik JE, et al. Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol. 2007;79(2):65-186.
47. Parker SE, Mai CT, Canfield MA, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008-1016.
48. Frohnert BK, Lussky RC, Alms MA, Mendelsohn NJ, Symonik DM, Falken MC. Validity of hospital discharge data for identifying infants with cardiac defects. J Perinatol. 2005;25(11):737-742.
49. Strickland MJ, Riehle-Colarusso TJ, Jacobs JP, et al. The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young. 2008;18(suppl 2):92-100.
50. Kumar RK, Newburger JW, Gauvreau K, Kamenir SA, Hornberger LK. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol. 1999;83(12):1649-1653.
51. Tham EB, Wald R, McElhinney DB, et al. Outcome of fetuses and infants with double inlet single left ventricle. Am J Cardiol. 2008;101(11):1652-1656.
52. Tworetzky W, McElhinney DB, Reddy VM, Brook MM, Hanley FL, Silverman NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation. 2001;103(9):1269-1273.
53. Allan L. Antenatal diagnosis of heart disease. Heart. 2000;83(3):367.
54. Boldt T, Andersson S, Eronen M. Outcome of structural heart disease diagnosed in utero. Scand Cardiovasc J. 2002;36(2):73-79.
55. Fesslova V, Nava S, Villa L, Fetal Cardiology Study Group of the Italian Society of Pediatric Cardiology. Evolution and long term outcome in cases with fetal diagnosis of congenital heart disease: Italian multicentre study. Heart. 1999;82(5):594-599.
56. Kuppermann M, Learman LA, Gates E, et al. Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol. 2006;107(5):1087-1097.
57. Peiris V, Singh TP, Tworetzky W, Chong EC, Gauvreau K, Brown DW. Association of socioeconomic position and medical insurance with fetal diagnosis of critical congenital heart disease. Circ Cardiovasc Qual Outcomes. 2009;2(4):354-360.
58. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20(4):488-495.